Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELIA trial of metformin for antipsychotic-induced weight gain
NL-OMON20221Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in antipsychotic-induced weight gain (AIWG) comparing Metformin + lifestyle intervention with Placebo + lifestyle intervention (2 arms). Primary endpoint: Change in body weight from baseline to week 26. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
antipsychotic-induced weight gain (AIWG)
Beyond the preview
Go deeper on NL-OMON20221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20221.